Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Apple smartwatches get a clinical boost from new studies

The trend: Two new studies show Apple Watches can improve detection and screening of a common irregular heart condition, atrial fibrillation (AFib).

  • Patients diagnosed with AFib who wore Apple Watches were notified more often of AFIb recurrences, but were less likely to have unplanned hospitalizations, per a UK study published recently.
  • A second study of high-risk stroke patients detected AFib in 9.6% of patients who wore Apple Watches at least 12 hours per day compared with 2.3% of patients who did not wear the watches, per a study in The Netherlands published recently.
  • Apple added AFib detection in 2018. Google’s Fitbit and Samsung’s Galaxy Watch followed in 2020.

Why it matters: Apple and other smart wearable makers are adding more health monitoring features, but healthcare professionals have been skeptical about their clinical value.

Key stat: Health and wellness features are the key drivers of consumer adoption of wearables, according to EMARKETER’s US Wearables Forecast 2025 report.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!